NFL: Reports: WFT trainer Ryan Vermillion subject of prescription drug probe

Date:

Share post:


Washington Football Team head trainer Ryan Vermillion is being investigated for illegally distributing prescription drugs, the Washington Post and ESPN reported Thursday.

Federal law enforcement conducted a raid at the team’s practice facility and Vermillion’s home last week. On Monday, Washington placed him on administrative leave, saying in a statement it was “due to an ongoing criminal investigation that is unrelated to the team.”

Vermillion is not a physician, so by law he would not be allowed to disburse prescription drugs.

Earlier Thursday, the NFLPA informed agents that it has begun its own investigation into the matter.

“The work office and home of Ryan Vermillion were raided by the Drug Enforcement Agency, and one of our players has been contacted by federal investigators,” the memo revealed.

According to the initial report from NBC Sports Washington, the investigation into Vermillion has been ongoing for months.

Vermillion is in his second season with Washington after 18 seasons with the Carolina Panthers. He spent nine seasons with Washington coach Ron Rivera in Carolina when Rivera was coach of the Panthers from 2011-19.

–Field Level Media

spot_img

Related articles

NCAAF: Five-star TE recruit Kaiden Prothro stays in-state with Georgia

Georgia and head football coach Kirby Smart added to a vaunted recruiting haul for the Class of 2026...

NFL: Browns RB Quinshon Judkins arrested on battery/domestic violence charge

Cleveland Browns rookie running back Quinshon Judkins is facing a charge of battery and domestic violence following a...

NFL: Chargers rookie WR Tre Harris holding out from training camp

Los Angeles Chargers rookie wide receiver Tre Harris is officially holding out from training camp. According to NFL...

NCAAF: Facing suspension, Jake Retzlaff withdraws from BYU

Embattled quarterback Jake Retzlaff announced Friday that he is withdrawing from BYU, a move that comes after he...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.